Doha-based team in cancer research breakthrough
Dr Bella Guerrouahen in the lab at WCMC-Q.
Cancer researchers at Weill Cornell Medical College in Qatar (WCMC-Q) have made a breakthrough that could lead to improved treatments for ovarian cancer, which causes the death of a large number of women across the world.
Dr Bella Guerrouahen, a postdoctoral associate in genetic medicine at WCMC-Q, has discovered one of the aspects of how and why a patient may build up resistance to the popular cancer drug bevacizumab, sold commercially as Avastin.
Read the full text news resource site…
Source News: Gulf Times
